These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 29181691)
1. Irreversible phenotypic perturbation and functional impairment of B cells during HIV-1 infection. Yan J; Zhang S; Sun J; Xu J; Zhang X Front Med; 2017 Dec; 11(4):536-547. PubMed ID: 29181691 [TBL] [Abstract][Full Text] [Related]
2. Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Cagigi A; Nilsson A; Pensieroso S; Chiodi F Lancet Infect Dis; 2010 Jul; 10(7):499-503. PubMed ID: 20610332 [TBL] [Abstract][Full Text] [Related]
3. Concerted effect of lymphopenia, viraemia and T-cell activation on Fas expression of peripheral B cells in HIV-1-infected patients. Rethi B; Sammicheli S; Amu S; Pensieroso S; Hejdeman B; Schepis D; Thang PH; Chiodi F AIDS; 2013 Jan; 27(2):155-62. PubMed ID: 23238551 [TBL] [Abstract][Full Text] [Related]
4. Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8 Veel E; Westera L; van Gent R; Bont L; Otto S; Ruijsink B; Rabouw HH; Mudrikova T; Wensing A; Hoepelman AIM; Borghans JAM; Tesselaar K Front Immunol; 2018; 9():572. PubMed ID: 29619031 [TBL] [Abstract][Full Text] [Related]
5. Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets. Pogliaghi M; Ripa M; Pensieroso S; Tolazzi M; Chiappetta S; Nozza S; Lazzarin A; Tambussi G; Scarlatti G PLoS One; 2015; 10(10):e0140435. PubMed ID: 26474181 [TBL] [Abstract][Full Text] [Related]
6. Impact of HIV infection and highly active antiretroviral therapy (HAART) on B cell subpopulations in children. Singh R; Mukherjee A; Singla M; Vajpayee M; Negi N; Kabra SK; Lodha R; Das BK J Med Virol; 2018 Jul; 90(7):1222-1231. PubMed ID: 29575050 [TBL] [Abstract][Full Text] [Related]
8. Persistent subclinical immune defects in HIV-1-infected children treated with antiretroviral therapy. van den Heuvel D; Driessen GJ; Berkowska MA; van der Burg M; Langerak AW; Zhao D; Charif H; Hartwig NG; van Rossum AM; Fraaij PL; van Dongen JJ; van Zelm MC AIDS; 2015 Sep; 29(14):1745-56. PubMed ID: 26372381 [TBL] [Abstract][Full Text] [Related]
9. HIV-associated memory B cell perturbations. Hu Z; Luo Z; Wan Z; Wu H; Li W; Zhang T; Jiang W Vaccine; 2015 May; 33(22):2524-9. PubMed ID: 25887082 [TBL] [Abstract][Full Text] [Related]
10. Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV. Bussmann BM; Reiche S; Bieniek B; Krznaric I; Ackermann F; Jassoy C Virology; 2010 Feb; 397(1):7-13. PubMed ID: 19962720 [TBL] [Abstract][Full Text] [Related]
11. Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway. Liu MQ; Zhao M; Kong WH; Tang L; Wang F; Zhu ZR; Wang X; Qiu HY; Zhou DJ; Wang X; Ho WZ; Zhou W Oncotarget; 2017 Apr; 8(14):22524-22533. PubMed ID: 28186978 [TBL] [Abstract][Full Text] [Related]
12. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895 [TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy. Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531 [TBL] [Abstract][Full Text] [Related]
14. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy. Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775 [TBL] [Abstract][Full Text] [Related]
15. Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy. Chaix ML; Seng R; Frange P; Tran L; Avettand-Fenoël V; Ghosn J; Reynes J; Yazdanpanah Y; Raffi F; Goujard C; Rouzioux C; Meyer L; Clin Infect Dis; 2013 Mar; 56(6):880-7. PubMed ID: 23223603 [TBL] [Abstract][Full Text] [Related]
16. Early Antiretroviral Therapy Preserves Functional Follicular Helper T and HIV-Specific B Cells in the Gut Mucosa of HIV-1-Infected Individuals. Planchais C; Hocqueloux L; Ibanez C; Gallien S; Copie C; Surenaud M; Kök A; Lorin V; Fusaro M; Delfau-Larue MH; Lefrou L; Prazuck T; Lévy M; Seddiki N; Lelièvre JD; Mouquet H; Lévy Y; Hüe S J Immunol; 2018 May; 200(10):3519-3529. PubMed ID: 29632141 [TBL] [Abstract][Full Text] [Related]
18. The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients. Redgrave BE; Stone SF; French MA; Krueger R; James IR; Price P HIV Med; 2005 Sep; 6(5):307-12. PubMed ID: 16156877 [TBL] [Abstract][Full Text] [Related]
19. Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. Moir S; Malaspina A; Ho J; Wang W; Dipoto AC; O'Shea MA; Roby G; Mican JM; Kottilil S; Chun TW; Proschan MA; Fauci AS J Infect Dis; 2008 Feb; 197(4):572-9. PubMed ID: 18240953 [TBL] [Abstract][Full Text] [Related]
20. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals. Martinson JA; Tenorio AR; Montoya CJ; Al-Harthi L; Gichinga CN; Krieg AM; Baum LL; Landay AL Immunology; 2007 Apr; 120(4):526-35. PubMed ID: 17343615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]